Format

Send to

Choose Destination
Clin Trials. 2004 Feb;1(1):122-30.

The Salk Polio Vaccine Trial of 1954: risks, randomization and public involvement in research.

Author information

1
The Phoebe R. Berman Bioethics Institute, The John Hopkins University, 624 N. Broadway, Hampton House Rm. 352, Baltimore, MD 21205, USA. dawsonl@mail.nih.gov

Abstract

The year 2004 marks the fiftieth anniversary of the celebrated 1954 Salk Polio Vaccine Trial. This enormous clinical trial, involving 1.8 million children, was carried out with the co-operation and assistance of hundreds of thousands of lay volunteers, along with medical professionals and local health departments throughout the USA. While the trial was an impressive public health achievement, firmly establishing the efficacy of the killed virus vaccine and paving the way for eradication of the disease, it was not without controversy. This article recounts the story of this important early clinical trial and how the social and political conditions at the time affected its planning and execution.

PMID:
16281467
DOI:
10.1191/1740774504cn010xx
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center